BRIEF published on 01/28/2026 at 18:53, 3 months 11 days ago ABIONYX: Publication of the Number of Voting Rights and Shares Euronext Paris Share Capital Voting Rights Financial Transparency ABIONYX
BRIEF published on 01/28/2026 at 18:53, 3 months 11 days ago ABIONYX : Publication du Nombre de Droits de Vote et d'Actions Euronext Paris Droits De Vote Capital Social Transparence Financière ABIONYX
PRESS RELEASE published on 01/28/2026 at 18:48, 3 months 11 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique le nombre de titres en circulation et de droits de vote, conformément aux réglementations en vigueur. Détails sur les actions et objectif de la société Droits De Vote Développement Biopharma ABIONYX Pharma Nombre De Titres
BRIEF published on 01/23/2026 at 19:05, 3 months 16 days ago ABIONYX Pharma unveils its 2026 financial calendar Critical Care Innovative Therapies ABIONYX Pharma Sepsis Financial Calendar 2026
BRIEF published on 01/23/2026 at 19:05, 3 months 16 days ago ABIONYX Pharma dévoile son calendrier financier 2026 ABIONYX Pharma Sepsis Thérapies Innovantes Calendrier Financier 2026 Soins Critiques
BRIEF published on 01/23/2026 at 19:05, 3 months 16 days ago ABIONYX Pharma Announces 2026 Financial Calendar Financial Calendar Biopharma ABIONYX Pharma 2026 Updates Sepsis Care
BRIEF published on 01/23/2026 at 19:05, 3 months 16 days ago ABIONYX Pharma annonce son calendrier financier pour 2026 Calendrier Financier Biopharma ABIONYX Pharma Mises À Jour 2026 Soins De La Septicémie
PRESS RELEASE published on 01/23/2026 at 19:00, 3 months 16 days ago Inside Information / Other news releases ABIONYX Pharma announces its financial calendar for 2026, including key events and dates for cash position updates and results releases Financial Calendar ABIONYX Pharma Sepsis 2026 Therapeutic Era
PRESS RELEASE published on 01/23/2026 at 19:00, 3 months 16 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce son calendrier de communication financière pour l’exercice 2026, incluant les résultats annuels et semestriels ainsi que les positions de trésorerie Communication Financière Biopharmaceutique ABIONYX Pharma Sepsis Calendrier 2026
BRIEF published on 01/07/2026 at 19:17, 4 months 1 day ago ABIONYX Pharma's Half-Yearly Review of Liquidity Contract Liquidity Contract TP ICAP Europe Stock Market Transactions ABIONYX Pharma Stocks And Cash
Published on 05/09/2026 at 01:30, 16 hours 49 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 18 hours 19 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 21 hours 41 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 23 hours 6 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 23 hours 17 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 23 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 23 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 23 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 23 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 23 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
